Diagnosis and management of cryptococcal disease in resource-limited settings

被引：6

作者：

Vanselow M. ^{[1
]}

Brandt M.E. ^{[1
]}

Park B.J. ^{[1
]}

机构：

[1] Mycotic Diseases Branch, Centers for Disease Control and Prevention, MS C-09, Atlanta, GA 30333

来源：

Current Fungal Infection Reports | 2012年 / 6卷 / 1期

关键词：

Amphotericin; Cryptococcal antigen; Cryptococcal meningitis; Cryptococcosis; Cryptococcus; Diagnosis; Fluconazole; HIV/AIDS; Lateral flow assay; Latex agglutination; Management; Resource-limited settings;

D O I：

10.1007/s12281-011-0082-6

中图分类号：

学科分类号：

摘要：

Cryptococcal meningitis is one of the most important fungal infections in the developing world, where deaths related to this disease are numerous. In resource-limited settings, mortality is high in large part because of difficulties in the diagnosis and management of this infection. This paper outlines many of the realities in many resource-limited settings, and describes priorities for public health action and research. © 2012 Springer Science+Business Media, LLC.

引用

页码：35 / 40

页数：5

共 39 条

[21]

Perry L., Malkin R., Effectiveness of medical equipment donations to improve health systems: How much medical equipment is broken in the developing world?, Med Biol Eng Comput., 49, 7, pp. 719-722, (2011)

[22]

Bimenya G.S., Nzarubara G.R., Et al., The accuracy of self monitoring blood glucose meter systems in Kampala Uganda, Afr Health Sci., 3, 1, pp. 23-32, (2003)

[23]

Harries A.D., Michongwe J., Nyirenda T.E., Kemp J.R., Squire S.B., Ramsay A.R., Godfrey-Faussett P., Salaniponi F.M., Using a bus service for transporting sputum specimens to the Central Reference Laboratory: Effect on the routine TB culture service in Malawi, International Journal of Tuberculosis and Lung Disease, 8, 2, pp. 204-210, (2004)

[24]

Frank U.K., Nishimura S.L., Li N.C., Sugai K., Yajko D.M., Hadley W.K., Ng V.L., Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid, Journal of Clinical Microbiology, 31, 1, pp. 97-101, (1993)

[25]

Tanner D.C., Weinstein M.P., Fedorciw B., Joho K.L., Thorpe J.J., Reller L.B., Comparison of commercial kits for detection of cryptococcal antigen, Journal of Clinical Microbiology, 32, 7, pp. 1680-1684, (1994)

[26]

Feldmesser M., Harris C., Reichberg S., Khan S., Casadevall A., Serum cryptococcal antigen in patients with AIDS, Clinical Infectious Diseases, 23, 4, pp. 827-830, (1996)

[27]

Meya D.B., Manabe Y.C., Et al., Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count or = 100 cells/microL who start HIV therapy in resource-limited settings, Clin Infect Dis., 51, 4, pp. 448-455, (2010)

[28]

Petti C.A., Polage C.R., Quinn T.C., Ronald A.R., Sande M.A., Laboratory medicine in Africa: A barrier to effective health care, Clinical Infectious Diseases, 42, 3, pp. 377-382, (2006)

[29]

Jarvis J.N., Percival A., Et al., Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis, Clin Infect Dis., 53, 10, pp. 1019-1023, (2011)

[30]

Lindsley M.D., Mekha N., Et al., Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis, Clin Infect Dis., 53, 4, pp. 321-325, (2011)

← 1 2 3 4 →